EPISODE · Mar 1, 2024 · 11 MIN
Why Does PrEP Use Lag in Cisgender Women?
from Healthy Dialogue
How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content: HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
Embed this episode
NOW PLAYING
Why Does PrEP Use Lag in Cisgender Women?
0:00
11:20
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Healthy Dialogue?
This episode is 11 minutes long.
When was this Healthy Dialogue episode published?
This episode was published on March 1, 2024.
Can I download this Healthy Dialogue episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!